SpectraScience Announces Licensing of Key Technology From Duke University
June 28 2016 - 9:15AM
Marketwired
SpectraScience Announces Licensing of Key Technology From Duke
University
SAN DIEGO, CA-(Marketwired - Jun 28, 2016) - SpectraScience,
Inc. (OTCQB: SCIE), a medical device company utilizing light
technologies to detect and diagnose cancers, announced today that
they have expanded their licensing agreement with Duke University
to include an additional patent. This patent is an enhancement to
the current license portfolio of intellectual property around
systems and methods for the use of Angle-Resolved Low Coherence
Interferometry in the diagnosis of certain cancers.
"We continue to look for opportunities to improve the breadth
and the depth of our Intellectual Property portfolio," said Michael
Oliver, President and Chief Executive Officer of SpectraScience,
Inc. "The patent we have added to our license with Duke University
will help us ensure freedom to operate within indications of
interest. With the potential to develop a product for light-based
diagnosis of Barrett's Esophagus, a precursor to esophageal cancer,
we will continue to broaden our product offerings. Our goal is to
be the premier company using light to provide in vivo diagnosis of
cancer."
About SpectraScience, Inc.:
SpectraScience is a San Diego based medical device company that
designs, develops, manufactures and markets spectrophotometry
systems capable of determining whether tissue is normal,
pre-cancerous or cancerous without physically removing tissue from
the body. Protected by more than 30 patents in 28 countries,
covering fundamental elements of the technology, the WavSTAT
Optical Biopsy System uses light to optically scan tissue and
provide the physician with an immediate analysis. With FDA approval
for sale in the U.S. and the CE Mark for the European Union, the
WavSTAT System is the first commercially available product that
incorporates this innovative patent protected technology for
clinical use.
For more information:
Visit our web site www.spectrascience.com
Forward-Looking Statement for SpectraScience, Inc.
This news release contains forward-looking statements that
involve risks and uncertainties that may cause SpectraScience's
actual results to differ materially from results discussed in
forward-looking statements. Readers are urged to carefully review
and consider the various disclosures made by SpectraScience in this
news release, its most recent Form 10-K and in SpectraScience's
other reports filed with the Securities and Exchange Commission
("SEC") that attempt to advise interested parties of the risks and
factors that may affect SpectraScience's business. These
forward-looking statements are qualified in their entirety by the
cautions and risk factors filed by SpectraScience in its annual
report on Form 10-K and other documents.
Contact Information
Contacts:Media and Investors:SpectraScience, Inc.Lowell
GiffhornCFOPhone: (858) 847-0200 x2019Email:
lgiffhorn@spectrascience.com
SpectraScience (CE) (USOTC:SCIE)
Historical Stock Chart
From Dec 2024 to Jan 2025
SpectraScience (CE) (USOTC:SCIE)
Historical Stock Chart
From Jan 2024 to Jan 2025
